Specialist in Rheumatology and Immunology, Lamine completed his path with a Certificate in Medical Statistics (CESAM) and several seminars in health management, the last of which was held in 2011 at the Harvard School of Public Health. After a transition in clinical rheumatology, he joined INSERM (French National Institute of Health and Medical Research) for projects in immunology and HIV . He started his career in industry at BYK-Gulden, before joining LFB as Senior Medical Officer in Immunology and Transgene, leading clinical projects in Europe and the USA in the field of gene therapy. In 2001, he joined Gilead Sciences as Associate Medical Director in the Anti-Infectious Diseases division, a role that was later extended to Development and Clinical Operations. In June 2009, he became Director of Vifor Pharma, creating the French subsidiary of this laboratory specialized in the treatment of anemias and supportive care in oncology. In 2013, with his experience, he founded “Axelys Santé – Medical Affairs and Clinical Research”, putting all his expertise at the disposal of drug companies, to support them in their clinical development and market access strategies.
.